UOC
KRTX

UBS O'Connor’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

UBS O'Connor’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-106,800
Closed -$33.8M – 627
2023
Q4 		$33.8M Buy
+106,800
New +$20.8M 1.06% 11

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

UBS O'Connor's KRTX Position: Q1 2024 in Review

UBS O'Connor sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 106,800 shares — an estimated $33.8M sold.

UBS O'Connor first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $33.8M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • UBS O'Connor reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • UBS O'Connor sold 106,800 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $33.8M.
  • UBS O'Connor first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • UBS O'Connor's Karuna Therapeutics, Inc. Common Stock position peaked at $33.8M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on UBS O'Connor's 13F filing for Q1 2024, filed 15 May 2024.